Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00514852 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
NCT00514852 is a NA study that has completed, run by Allergan. The registered enrollment target is 316 participants.
The verdict
NCT00514852, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
Study Summary
The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear
Interventions
- DRUG Carboxymethylcellulose and Glycerin based artificial tear
- DRUG Carboxymethylcellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00514852
The ClinicalTrials.gov registry entry for NCT00514852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carboxymethylcellulose and Glycerin based artificial tear is the first listed.
NCT00514852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00514852 about?
NCT00514852 is a clinical study titled "Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye". The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear
What is the current status of trial NCT00514852?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2007-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00514852?
The interventions under investigation include: Carboxymethylcellulose and Glycerin based artificial tear (DRUG), Carboxymethylcellulose (DRUG).
Who is sponsoring clinical trial NCT00514852?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.